GlassScriptPhysician profile
Linda W Chan
NPI 1083844427
$597.72
in general payments reported to CMS, 2019-2025
12 companies · $72.16 in 2025
The $72.16 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.83 · 2020: $42.74 · 2021: $198 · 2022: $130 · 2023: $17.64 · 2024: $89.92 · 2025: $72.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $236.25 | 2019-2023 | Optune |
| Reflexion Medical, INC. | $75.00 | 2022-2024 | Reflexion Medical Radiotherapy System |
| Siemens Medical Solutions USA, INC. | $73.24 | 2022-2025 | Varian Ethos Treatment Planning |
| Bioprotect Medical, INC. | $43.02 | 2025 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $32.78 | 2022 | |
| Ge Healthcare | $27.89 | 2021 | |
| Progenics Pharmaceuticals, INC. | $27.86 | 2022 | |
| Varian Medical Systems, INC. | $21.96 | 2020 | |
| Sensus Healthcare, INC. | $21.19 | 2024 | |
| Ambu INC. | $19.80 | 2021 | |
| Ironwood Pharmaceuticals, INC | $18.73 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.